Daily Healthcare St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Healthcare St. Lucia.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 4, 2026

Mar. 4, 2026

NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET

GlobeNewswire

Mar. 4, 2026

Ardelyx to Participate in Upcoming Investor Conferences

GlobeNewswire

Mar. 4, 2026

Elutia Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire

Mar. 4, 2026

SpyGlass Pharma to Participate in the Jefferies Biotech on the Beach Summit

GlobeNewswire

Mar. 4, 2026

Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study

GlobeNewswire

Mar. 4, 2026

Tevogen Announces Reverse Stock Split

GlobeNewswire

Mar. 4, 2026

Fort Wayne Medical Oncology and Hematology and Cameron Health Partner to Increase Access to Community Cancer Care in Angola, Indiana

GlobeNewswire

Mar. 4, 2026

ICAN Poll: Overwhelming Majority of Respondents Oppose Glyphosate Stockpiling, Reject Manufacturer Immunity

GlobeNewswire

Mar. 4, 2026

Firefly Progresses Toward Development and Commercial Launch of its Foundation Model of the Human Brain Powered by NVIDIA GPU Acceleration

GlobeNewswire

Mar. 4, 2026

EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

GlobeNewswire

Mar. 4, 2026

Landmark Data Validate BrainsWay’s SWIFT™ Deep TMS, Beginning a New Era in Depression Treatment

GlobeNewswire

Mar. 4, 2026

Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign

GlobeNewswire

Mar. 4, 2026

BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference

GlobeNewswire

Mar. 4, 2026

NervGen Pharma Appoints Shamim Ruff as Chief Regulatory Affairs Officer and Christine McSherry as SVP, Patient Advocacy and Clinical Affairs

GlobeNewswire

Mar. 4, 2026

CervoMed Announces Selection of Formulation and Dosing Regimen for Planned Phase 3 Trial in Patients with Dementia with Lewy Bodies

GlobeNewswire

Mar. 4, 2026

Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval

GlobeNewswire

Mar. 4, 2026

Alterity Therapeutics Appoints Daniel O. Claassen, M.D., M.S., as Chief Medical Advisor

GlobeNewswire

Mar. 4, 2026

Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase-Free)

GlobeNewswire

Mar. 4, 2026

Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

GlobeNewswire

Mar. 4, 2026

Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute

GlobeNewswire